A Study of Biomarkers for Human Heart Failure

Overview

About this study

The purpose of this study is to attempt to establish the various ranges of proteins that can be assayed from the plasma and urine of patients with all classes of heart failure and MI (myocardial infarction).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:       

  • Patients hospitalized with acute heart failure and/or STEMI/NSTEMI

Exclusion Criteria:      

  • Hemoglobin less than 10, active cancer, amyloidosis

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Burnett, M.D.

Open for enrollment

Contact information:

Sherry Benike R.N.

(507)266-3629

benike.sherry@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available